CytoReason vs Oriel Research
CytoReason vs Oriel Research, compared side by side on 13 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CytoReason is on 68/100 and Oriel Research on 12/100.
Where each one leads
CytoReason
- our overall score: 68/100 against 12/100
- domain rating: 40/100 against 0/100
- headcount: 116 against 6
Oriel Research
Leads on none of the measures we hold for both companies.
At a glance
| Measure | CytoReason | Oriel Research |
|---|---|---|
| What it is | Develops a computational model of the human body for drug discovery and development. | Crowdsourcing genomic data to discover disease markers and therapy correlations for personalized medicine. |
| Category | Healthcare, Drug Discovery, Clinical Development, Biomarkers | Healthcare, Genomics, HealthTech, Drug Discovery |
| Sells toBusiness model | B2B | B2C |
| Offering | Software | Software |
| Founded | 2016 | 2017 |
| Headquarters | Tel Aviv, Israel | Not published |
| Status | Active | Inactive |
Size, funding and growth
| Measure | CytoReason | Oriel Research |
|---|---|---|
| Employees | 116 | 6 |
| Headcount growthLast 12 months | +13.7% | Not published |
| Total funding | $128M | Not published |
| Latest round | Series B | Bootstrapped |
| LinkedIn followers | 12,830 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | CytoReason | Oriel Research |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 68/100 | 12/100 |
| Traction | 60/100 | 8/100 |
| Team | 70/100 | Not published |
| Search visibility | 30/100 | 9/100 |
| Quality | 78/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (22/100) |
| Domain ratingLink authority, 0-100 | 40/100 | 0/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | CytoReason | Oriel Research |
|---|---|---|
| Analytics | Segment | Not detected |
CytoReason vs Oriel Research: common questions
Which is better, CytoReason or Oriel Research?
On our 0-100 score CytoReason rates higher (68/100 against 12/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 13 data points above: read the rows that match what you are buying for.
How do CytoReason and Oriel Research compare on the numbers?
CytoReason leads on our overall score (68/100 against 12/100), domain rating (40/100 against 0/100), headcount (116 against 6).
Read the full CytoReason review and pricing or the Oriel Research review and pricing. You can also browse other CytoReason alternatives we track.